Kallol Ray Chaudhuri
#103,234
Most Influential Person Now
Researcher
Kallol Ray Chaudhuri's AcademicInfluence.com Rankings
Kallol Ray Chaudhuricomputer-science Degrees
Computer Science
#3718
World Rank
#3908
Historical Rank
Computational Linguistics
#243
World Rank
#247
Historical Rank
Machine Learning
#523
World Rank
#529
Historical Rank
Artificial Intelligence
#729
World Rank
#740
Historical Rank
Download Badge
Computer Science
Kallol Ray Chaudhuri's Degrees
- PhD Computer Science Stanford University
- Masters Computer Science University of California, Berkeley
Similar Degrees You Can Earn
Why Is Kallol Ray Chaudhuri Influential?
(Suggest an Edit or Addition)Kallol Ray Chaudhuri's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Non-motor symptoms of Parkinson's disease: diagnosis and management (2006) (2235)
- Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment (2009) (1391)
- Non-motor features of Parkinson disease (2017) (965)
- International multicenter pilot study of the first comprehensive self‐completed nonmotor symptoms questionnaire for Parkinson's disease: The NMSQuest study (2006) (912)
- The metric properties of a novel non‐motor symptoms scale for Parkinson's disease: Results from an international pilot study (2007) (819)
- The impact of non‐motor symptoms on health‐related quality of life of patients with Parkinson's disease (2011) (769)
- Cognitive decline in Parkinson disease (2017) (608)
- The Parkinson’s disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson’s disease (2002) (582)
- Motor neuron disease. (1994) (515)
- Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; Study using nonmotor symptoms questionnaire in 545 patients (2007) (511)
- Update on treatments for nonmotor symptoms of Parkinson's disease—an evidence‐based medicine review (2019) (492)
- Parkinson's disease symptoms: The patient's perspective (2010) (476)
- Rotigotine Effects on Early Morning Motor Function and Sleep in Parkinson's Disease: A Double-Blind, Randomized, pLacebo-Controlled Study (RECOVER) (2010) (398)
- Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study. (1996) (390)
- The nondeclaration of nonmotor symptoms of Parkinson's disease to health care professionals: An international study using the nonmotor symptoms questionnaire (2010) (363)
- Progression of dysarthria and dysphagia in postmortem-confirmed parkinsonian disorders. (2001) (347)
- Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) (1996) (337)
- Parkinson's disease: the non-motor issues. (2011) (332)
- Accuracy of the clinical diagnoses of Lewy body disease, Parkinson disease, and dementia with Lewy bodies: a clinicopathologic study. (1998) (316)
- Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination (1998) (300)
- Accuracy of the Clinical Diagnosis of Corticobasal Degeneration (1997) (298)
- Fatigue in Parkinson's disease is linked to striatal and limbic serotonergic dysfunction. (2010) (281)
- Parkinson's disease sleep scale—validation of the revised version PDSS‐2 (2011) (274)
- Practice Parameter: Treatment of nonmotor symptoms of Parkinson disease (2010) (271)
- Non motor subtypes and Parkinson's disease. (2016) (256)
- Intrajejunal levodopa infusion in Parkinson's disease: A pilot multicenter study of effects on nonmotor symptoms and quality of life (2009) (254)
- The non-motor symptom complex of Parkinson’s disease: A comprehensive assessment is essential (2005) (254)
- Nonmotor features of Parkinson's disease subtypes (2016) (242)
- International study on the psychometric attributes of the Non-Motor Symptoms Scale in Parkinson disease (2009) (227)
- The psychosis spectrum in Parkinson disease (2017) (224)
- Cortical dysfunction in non-demented Parkinson's disease patients: a combined (31)P-MRS and (18)FDG-PET study. (2000) (212)
- Efficacy of rotigotine for treatment of moderate-to-severe restless legs syndrome: a randomised, double-blind, placebo-controlled trial (2008) (204)
- Nonmotor fluctuations in Parkinson disease (2013) (203)
- EuroInf: A Multicenter Comparative Observational Study of Apomorphine and Levodopa Infusion in Parkinson's Disease (2015) (202)
- Parkinson's disease is overdiagnosed clinically at baseline in diagnostically uncertain cases: A 3‐year European multicenter study with repeat [123I]FP‐CIT SPECT (2009) (200)
- What is the accuracy of the clinical diagnosis of multiple system atrophy? A clinicopathologic study. (1997) (200)
- Microglia, Amyloid, and Glucose Metabolism in Parkinson’s Disease with and without Dementia (2013) (199)
- Gender-related differences in the burden of non-motor symptoms in Parkinson’s disease (2012) (196)
- Time course of symptomatic orthostatic hypotension and urinary incontinence in patients with postmortem confirmed parkinsonian syndromes: a clinicopathological study (1999) (183)
- Outcome of Parkinson's Disease Patients Affected by COVID‐19 (2020) (177)
- Parkinson's disease severity levels and MDS-Unified Parkinson's Disease Rating Scale. (2015) (172)
- Influence of microglial activation on neuronal function in Alzheimer's and Parkinson's disease dementia (2015) (170)
- Non-motor features of Parkinson disease (2017) (170)
- Non-motor Parkinson's: integral to motor Parkinson's, yet often neglected (2014) (168)
- Neuropsychiatric symptoms and caregiver's burden in Parkinson's disease. (2015) (162)
- Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial (2018) (161)
- Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? A clinicopathological study. (1997) (161)
- Practice guideline summary: Treatment of restless legs syndrome in adults (2016) (160)
- The Nonmotor Features of Parkinson's Disease. (2017) (160)
- King's Parkinson's disease pain scale, the first scale for pain in PD: An international validation (2015) (158)
- Progression of falls in postmortem‐confirmed Parkinsonian disorders (1999) (158)
- Parkinson’s: a syndrome rather than a disease? (2016) (153)
- A multicentre longitudinal observational study of changes in self reported health status in people with Parkinson’s disease left untreated at diagnosis (2006) (152)
- Nocturnal subcutaneous apomorphine infusion in Parkinson's disease and restless legs syndrome (1999) (150)
- The challenge of non-motor symptoms in Parkinson's disease. (2010) (147)
- Dysautonomia rating scales in Parkinson's disease: Sialorrhea, dysphagia, and constipation—Critique and recommendations by movement disorders task force on rating scales for Parkinson's disease (2009) (147)
- Rotigotine and specific non-motor symptoms of Parkinson's disease: post hoc analysis of RECOVER. (2013) (145)
- Collective physician perspectives on non-oral medication approaches for the management of clinically relevant unresolved issues in Parkinson's disease: Consensus from an international survey and discussion program. (2015) (144)
- Quantitation of non‐motor symptoms in Parkinson’s disease (2008) (143)
- Parkinson disease-associated cognitive impairment (2021) (141)
- Sleep-related problems of Parkinson's disease. (2006) (135)
- Measuring brain stem and cerebellar damage in parkinsonian syndromes using diffusion tensor MRI (2006) (133)
- Trial of CBT for impulse control behaviors affecting Parkinson patients and their caregivers (2013) (131)
- Early Parkinson’s disease and non-motor issues (2008) (124)
- Algorithms for the diagnosis and treatment of restless legs syndrome in primary care (2011) (124)
- Expert Consensus Group report on the use of apomorphine in the treatment of Parkinson's disease--Clinical practice recommendations. (2015) (124)
- Levodopa-carbidopa intestinal gel in advanced Parkinson's: Final results of the GLORIA registry. (2017) (121)
- Selecting deep brain stimulation or infusion therapies in advanced Parkinson’s disease: an evidence-based review (2013) (118)
- Long-term clinical and positron emission tomography outcome of fetal striatal transplantation in Huntington’s disease (2008) (115)
- Small fiber neuropathy in Parkinson's disease: A clinical, pathological and corneal confocal microscopy study (2015) (115)
- Personalized medicine in Parkinson's disease: Time to be precise (2017) (113)
- Chronic subcutaneous infusion therapy with apomorphine in advanced Parkinson's disease compared to conventional therapy: a real life study of non motor effect. (2011) (110)
- A study of excessive daytime sleepiness and its clinical significance in three groups of Parkinson's disease patients taking pramipexole, cabergoline and levodopa mono and combination therapy (2001) (105)
- Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease (2001) (102)
- Effect of pramipexole on RLS symptoms and sleep: a randomized, double-blind, placebo-controlled trial. (2008) (99)
- EuroInf 2: Subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson's disease (2019) (99)
- The range and nature of sleep dysfunction in untreated Parkinson's disease (PD). A comparative controlled clinical study using the Parkinson's disease sleep scale and selective polysomnography (2006) (98)
- Long duration asymmetrical postural tremor is likely to predict development of Parkinson’s disease and not essential tremor: clinical follow up study of 13 cases (2004) (97)
- Prolonged-release oxycodone–naloxone for treatment of severe pain in patients with Parkinson's disease (PANDA): a double-blind, randomised, placebo-controlled trial (2015) (96)
- Non-motor symptoms of Parkinson's disease A review…from the past (2014) (95)
- Assessing the non‐motor symptoms of Parkinson's disease: MDS‐UPDRS and NMS Scale (2015) (94)
- A Proposal for a Comprehensive Grading of Parkinson's Disease Severity Combining Motor and Non-Motor Assessments: Meeting an Unmet Need (2013) (93)
- Parkinson's Disease Subtypes Identified from Cluster Analysis of Motor and Non-motor Symptoms (2017) (93)
- Excessive Daytime Sleepiness in Patients with Parkinson’s Disease (2011) (90)
- Symptoms and Quality of Life in Late Stage Parkinson Syndromes: A Longitudinal Community Study of Predictive Factors (2012) (89)
- No association between Parkinson's disease and low-activity alleles of catechol O-methyltransferase. (1996) (88)
- The burden of non-motor symptoms in Parkinson's disease using a self-completed non-motor questionnaire: a simple grading system. (2015) (88)
- Changes in putamen N-acetylaspartate and choline ratios in untreated and levodopa-treated Parkinson's disease: A proton magnetic resonance spectroscopy study (1997) (87)
- Symptom prevalence, severity and palliative care needs assessment using the Palliative Outcome Scale: A cross-sectional study of patients with Parkinson’s disease and related neurological conditions (2013) (86)
- Improvements in nocturnal symptoms with ropinirole prolonged release in patients with advanced Parkinson’s disease (2012) (85)
- Autonomic dysfunction in movement disorders (2001) (85)
- A Consensus Set of Outcomes for Parkinson’s Disease from the International Consortium for Health Outcomes Measurement (2017) (85)
- New clinical trials for nonmotor manifestations of Parkinson's disease (2015) (83)
- Management of impulse control disorders in Parkinson's disease: Controversies and future approaches (2015) (83)
- COVID-19 and possible links with Parkinson’s disease and parkinsonism: from bench to bedside (2020) (83)
- Late onset levodopa responsive Huntington's disease with minimal chorea masquerading as Parkinson plus syndrome (2000) (82)
- Motor and nonmotor complications in Parkinson’s disease: an argument for continuous drug delivery? (2013) (82)
- Non-motor outcomes depend on location of neurostimulation in Parkinson's disease. (2019) (82)
- Non-motor outcomes depend on location of neurostimulation in Parkinson's disease. (2019) (82)
- Beneficial Effects of Bilateral Subthalamic Stimulation on Non-Motor Symptoms in Parkinson's Disease (2016) (81)
- Correlating rates of cerebral atrophy in Parkinson's disease with measures of cognitive decline (2001) (81)
- Clinical features differentiating patients with postmortem confirmed progressive supranuclear palsy and corticobasal degeneration (1999) (78)
- SCOPA‐sleep and PDSS: Two scales for assessment of sleep disorder in Parkinson's disease (2008) (77)
- The range and nature of non-motor symptoms in drug-naive Parkinson’s disease patients: a state-of-the-art systematic review (2015) (76)
- Nocturnal symptom complex in PD and its management (2003) (76)
- Impulse control disorders in Parkinson's disease: decreased striatal dopamine transporter levels (2013) (75)
- SUBCUTANEOUS APOMORPHINE FOR ON-OFF OSCILLATIONS IN PARKINSON'S DISEASE (1988) (74)
- A Randomized Controlled Exploratory Pilot Study to Evaluate the Effect of Rotigotine Transdermal Patch on Parkinson's Disease–Associated Chronic Pain (2016) (74)
- A randomised placebo controlled exploratory study of vitamin B-12, lofepramine, and L-phenylalanine (the “Cari Loder regime”) in the treatment of multiple sclerosis (2002) (74)
- Using a smartphone-based self-management platform to support medication adherence and clinical consultation in Parkinson’s disease (2016) (73)
- Atypical parkinsonism in Afro‐Caribbean and Indian origin immigrants to the UK (2000) (72)
- Characterizing motor and non-motor aspects of early-morning off periods in Parkinson's disease: an international multicenter study. (2014) (72)
- Motor and Nonmotor Complications of Levodopa: Phenomenology, Risk Factors, and Imaging Features (2018) (71)
- Evidence for cortical dysfunction in clinically non-demented patients with Parkinson’s disease: a proton MR spectroscopy study (1999) (71)
- A polymorphism in the dopamine receptor DRD5 is associated with blepharospasm (2002) (69)
- Nonmotor symptoms evolution during 24 months of bilateral subthalamic stimulation in Parkinson's disease (2018) (68)
- A European multicentre survey of impulse control behaviours in Parkinson's disease patients treated with short‐ and long‐acting dopamine agonists (2016) (68)
- The cost-effectiveness of deep brain stimulation in combination with best medical therapy, versus best medical therapy alone, in advanced Parkinson’s disease (2013) (68)
- Diffusion Tensor Imaging of Parkinson’s Disease, Multiple System Atrophy and Progressive Supranuclear Palsy: A Tract-Based Spatial Statistics Study (2014) (68)
- A detailed clinical study of pain in 1957 participants with early/moderate Parkinson's disease (2018) (67)
- Use of apomorphine in parkinsonian patients with neuropsychiatric complications to oral treatment. (1997) (66)
- Viewpoint and practical recommendations from a movement disorder specialist panel on objective measurement in the clinical management of Parkinson’s disease (2018) (64)
- Risk factors for early psychosis in PD: insights from the Parkinson's Progression Markers Initiative (2017) (64)
- Oral and Infusion Levodopa-Based Strategies for Managing Motor Complications in Patients with Parkinson’s Disease (2010) (64)
- Effects of rotigotine transdermal patch in patients with Parkinson's disease presenting with non‐motor symptoms – results of a double‐blind, randomized, placebo‐controlled trial (2015) (64)
- A comparison of 18F-dopa PET and inversion recovery MRI in the diagnosis of Parkinson’s disease (2001) (62)
- The validation of El Escorial criteria for the diagnosis of amyotrophic lateral sclerosis: A clinicopathological study (1995) (61)
- Abnormality of superior mesenteric artery blood flow responses in human sympathetic failure. (1992) (61)
- What are the obstacles for an accurate clinical diagnosis of Pick's disease? A clinicopathologic study (1997) (60)
- Accuracy of screening instruments for detection of neuropsychiatric syndromes in Parkinson's disease (2016) (57)
- Non‐motor symptoms burden in treated and untreated early Parkinson's disease patients: argument for non‐motor subtypes (2015) (57)
- The role of gut dysbiosis in Parkinson's disease: mechanistic insights andtherapeutic options. (2021) (56)
- Two novel mutations in the gene for copper zinc superoxide dismutase in UK families with amyotrophic lateral sclerosis. (1995) (56)
- Intrajejunal Levodopa Versus Conventional Therapy in Parkinson Disease: Motor and Nonmotor Effects (2012) (55)
- Non‐motor Parkinson disease: new concepts and personalised management (2018) (54)
- Pain in Parkinson's disease: facts and uncertainties (2018) (54)
- Non-motor symptoms: identification and management. (2007) (54)
- Rotigotine transdermal system and evaluation of pain in patients with Parkinson’s disease: a post hoc analysis of the RECOVER study (2014) (53)
- Anatomical and functional correlates of persistent pain in Parkinson's disease (2016) (53)
- Clinical assessment of nocturnal disability in Parkinson’s disease (2004) (52)
- Review of diagnostic instruments for the restless legs syndrome/Willis-Ekbom Disease (RLS/WED): critique and recommendations. (2014) (52)
- Unveiling relevant non-motor Parkinson's disease severity symptoms using a machine learning approach (2013) (51)
- Non-oral dopaminergic therapies for Parkinson’s disease: current treatments and the future (2016) (51)
- [18F]FDOPA uptake in the raphe nuclei complex reflects serotonin transporter availability. A combined [18F]FDOPA and [11C]DASB PET study in Parkinson's disease (2012) (50)
- A case of systemic lupus erythematosus presenting as Guillain-Barré syndrome. (1989) (50)
- Quantitative assessment of non-motor fluctuations in Parkinson’s disease using the Non-Motor Symptoms Scale (NMSS) (2015) (50)
- Impulse control disorder related behaviours during long‐term rotigotine treatment: a post hoc analysis (2016) (49)
- Cortical Thickness, Surface Area and Volume Measures in Parkinson's Disease, Multiple System Atrophy and Progressive Supranuclear Palsy (2014) (49)
- Parkinson's disease sleep scale: Validation study of a Spanish version (2004) (48)
- New concepts in the pathogenesis and presentation of Parkinson's disease. (2016) (47)
- Amyloid-β and Parkinson’s disease (2018) (47)
- Serotonergic dysregulation is linked to sleep problems in Parkinson's disease (2018) (47)
- ‘Sleep Attacks’ or ‘Unintended Sleep Episodes’ Occur with Dopamine Agonists (2002) (47)
- Postprandial hypotension and parkinsonian state in parkinson's disease (1997) (46)
- The Movement Disorder Society Nonmotor Rating Scale: Initial Validation Study (2020) (46)
- Infusion Therapies and Development of Impulse Control Disorders in Advanced Parkinson Disease: Clinical Experience After 3 Years’ Follow-up (2015) (46)
- Perceptions of symptoms and expectations of advanced therapy for Parkinson’s disease: preliminary report of a Patient-Reported Outcome tool for Advanced Parkinson’s disease (PRO-APD) (2014) (46)
- Advanced Parkinson’s or “complex phase” Parkinson’s disease? Re-evaluation is needed (2017) (45)
- Non-motor outcomes of subthalamic stimulation in Parkinson's disease depend on location of active contacts (2018) (45)
- Retrospective evaluation of cardio-pulmonary fibrotic side effects in symptomatic patients from a group of 234 Parkinson’s disease patients treated with cabergoline (2005) (45)
- Crystallisation within transdermal rotigotine patch: is there cause for concern? (2008) (44)
- Drooling in Parkinson’s Disease: Prevalence and Progression from the Non-motor International Longitudinal Study (2020) (43)
- Nature and variants of idiopathic restless legs syndrome: observations from 152 patients referred to secondary care in the UK (2007) (43)
- Physiological assessment of aspects of autonomic function in patients with secondary progressive multiple sclerosis (2004) (43)
- Non-motor symptoms: the core of multi-morbid Parkinson's disease. (2014) (43)
- Retrospective application of a set of clinical diagnostic criteria for the diagnosis of multiple system atrophy (1998) (43)
- Effective Delivery of Apomorphine in the Management of Parkinson Disease: Practical Considerations for Clinicians and Parkinson Nurses (2015) (42)
- Subcutaneous apomorphine and non-motor symptoms in Parkinson's disease. (2013) (42)
- Clinical significance of RLS (2007) (41)
- A cost-effectiveness analysis of levodopa/carbidopa intestinal gel compared to standard care in late stage Parkinson’s disease in the UK (2011) (41)
- The neuropsychiatry of Parkinson's disease: advances and challenges (2022) (41)
- Growth hormone response to clonidine in central and peripheral primary autonomic failure (1992) (41)
- Nonmotor symptoms and focal cervical dystonia: Observations from 102 patients (2014) (40)
- Nonmotor predictors for levodopa requirement in de novo patients with Parkinson's disease (2015) (40)
- Quality of life outcome after subthalamic stimulation in Parkinson's disease depends on age (2018) (40)
- Non-motor symptoms profile and burden in drug naïve versus long-term Parkinson's disease patients. (2014) (40)
- Should there be less emphasis on levodopa‐induced dyskinesia in Parkinson's disease? (2019) (39)
- Assessment and Management of Neuropsychiatric Symptoms in Parkinson’s Disease (2018) (38)
- Pain in Parkinson's disease: new concepts in pathogenesis and treatment. (2019) (38)
- Non-Motor Symptoms in Patients Suffering from Motor Neuron Diseases (2016) (38)
- Parkinson's Disease and Post–COVID‐19 Syndrome: The Parkinson's Long‐COVID Spectrum (2021) (38)
- Erythropoietin deficiency and anaemia in multiple system atrophy (2001) (37)
- Hypersensitivity to carbamazepine presenting with a leukemoid reaction, eosinophilia, erythroderma, and renal failure (1989) (37)
- Gastrointestinal dysfunction in Parkinson’s disease: molecular pathology and implications of gut microbiome, probiotics, and fecal microbiota transplantation (2021) (37)
- How integrated are neurology and palliative care services? Results of a multicentre mapping exercise (2016) (37)
- Night‐time sleep in Parkinson's disease – the potential use of Parkinson's KinetiGraph: a prospective comparative study (2016) (36)
- Subcutaneous apomorphine in Parkinson's disease (1998) (36)
- Limited joint mobility and carpal tunnel syndrome in insulin-dependent diabetes. (1989) (36)
- Management of Psychosis in Parkinson's Disease: Emphasizing Clinical Subtypes and Pathophysiological Mechanisms of the Condition (2017) (35)
- Smartphone- and internet-assisted self-management and adherence tools to manage Parkinson’s disease (SMART-PD): study protocol for a randomised controlled trial (v7; 15 August 2014) (2014) (35)
- Psychometric properties of the Parkinson's Disease Sleep Scale--Brazilian version. (2009) (35)
- Potential of animal models for advancing the understanding and treatment of pain in Parkinson’s disease (2020) (35)
- Cardiovascular and hormonal responses to liquid food challenge in idiopathic Parkinson's disease, multiple system atrophy, and pure autonomic failure (1993) (35)
- Acupuncture Effect and Mechanism for Treating Pain in Patients With Parkinson's Disease (2019) (34)
- Achieving 24-Hour Control of Parkinson’s Disease Symptoms: Use of Objective Measures to Improve Nocturnal Disability (2001) (34)
- Personalized Medicine and Nonmotor Symptoms in Parkinson's Disease. (2017) (34)
- Rating Scales for Pain in Parkinson's Disease: Critique and Recommendations (2016) (34)
- Valvular heart disease and fibrotic reactions may be related to ergot dopamine agonists, but non‐ergot agonists may also not be spared (2004) (34)
- Short-term quality of life after subthalamic stimulation depends on non-motor symptoms in Parkinson's disease (2018) (33)
- Primary anticholinergic‐responsive Pisa syndrome (2000) (33)
- Non-motor symptoms in a Flanders-Belgian population of 215 Parkinson's disease patients as assessed by the Non-Motor Symptoms Questionnaire. (2012) (33)
- Parkinson's disease in populations of African origin: a review. (1996) (33)
- Review of Severity Rating Scales for Restless Legs Syndrome: Critique and Recommendations (2014) (32)
- The restless legs syndrome (2003) (32)
- Non-motor Symptoms Questionnaire und Scale für das idiopathische Parkinson-Syndrom (2010) (32)
- Dopamine receptor agonists and sleep disturbances in Parkinson's disease. (2009) (32)
- Distribution and impact on quality of life of the pain modalities assessed by the King’s Parkinson’s disease pain scale (2017) (31)
- Clinically relevant cut-off values for the Parkinson's Disease Sleep Scale-2 (PDSS-2): a validation study. (2016) (31)
- The Non‐Motor Symptoms Scale in Parkinson’s disease: Validation and use (2020) (31)
- Depression and Catechol-O-methyltransferase (COMT) genetic variants are associated with pain in Parkinson’s disease (2017) (30)
- Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson’s disease: evidence for dopaminergic basis? (2017) (30)
- Noninvasive quantification of superior mesenteric artery blood flow during sympathoneural activation in normal subjects (1991) (30)
- A comparison of (18)F-dopa PET and inversion recovery MRI in the diagnosis of Parkinson's disease. (2001) (30)
- An update of the impact of deep brain stimulation on non motor symptoms in Parkinson's disease. (2014) (30)
- Sleep problems and hypothalamic dopamine D3 receptor availability in Parkinson disease (2016) (29)
- [Non-motor Symptoms Questionnaire and Scale for Parkinson's disease. Cross-cultural adaptation into the German language]. (2010) (29)
- Therapy of Parkinson’s Disease Subtypes (2020) (29)
- Limb contractures in levodopa-responsive parkinsonism: a clinical and investigational study of seven new cases (1999) (28)
- Unmet needs in Parkinson disease: Motor and non-motor. (2020) (28)
- Motor Impairment Estimates via Touchscreen Typing Dynamics Toward Parkinson's Disease Detection From Data Harvested In-the-Wild (2018) (28)
- MRI changes in multiple sclerosis following treatment with lofepramine and l-phenylalanine (2001) (28)
- The role of self-awareness and cognitive dysfunction in Parkinson's disease with and without impulse-control disorder. (2013) (28)
- Parkinson disease: Unravelling the nonmotor mysteries of Parkinson disease (2015) (27)
- Comprehensive grading of Parkinson’s disease using motor and non-motor assessments: addressing a key unmet need (2018) (27)
- COVID-19 and possible links with Parkinson’s disease and parkinsonism: from bench to bedside (2020) (27)
- Progression of sleep disturbances in Parkinson’s disease: a 5-year longitudinal study (2020) (27)
- Detecting Parkinsonian Tremor From IMU Data Collected in-the-Wild Using Deep Multiple-Instance Learning (2019) (27)
- Diagnosing restless legs syndrome (RLS) in primary care (2004) (27)
- Understanding the role of the Parkinson's disease nurse specialist in the delivery of apomorphine therpy. (2016) (27)
- Accuracy of the clinical diagnosis of postencephalitic parkinsonism: a clinicopathologic study (1998) (27)
- Recommendations for the Organization of Multidisciplinary Clinical Care Teams in Parkinson’s Disease (2020) (26)
- ‘Levodopa Phobia’: a review of a not uncommon and consequential phenomenon (2018) (26)
- Alcohol ingestion lowers supine blood pressure, causes splanchnic vasodilatation and worsens postural hypotension in primary autonomic failure (2004) (26)
- Improvement of dyskinesias with l‐dopa infusion in advanced Parkinson's disease (2016) (26)
- Barriers to reporting non-motor symptoms to health-care providers in people with Parkinson's. (2019) (26)
- Identifying and responding to fatigue and apathy in Parkinson’s disease: a review of current practice (2020) (26)
- Subthalamic Stimulation Improves Quality of Life of Patients Aged 61 Years or Older With Short Duration of Parkinson's Disease (2018) (25)
- A prospective, controlled study of non-motor effects of subthalamic stimulation in Parkinson’s disease: results at the 36-month follow-up (2020) (25)
- Parkinson's Impulse‐Control Scale for the Severity Rating of Impulse‐Control Behaviors in Parkinson's Disease: A Semistructured Clinical Assessment Tool (2016) (25)
- Continuous Drug Delivery Aiming Continuous Dopaminergic Stimulation in Parkinson’s Disease (2018) (24)
- Narcolepsy in Parkinson’s disease (2010) (24)
- Spontaneous dissections of the internal carotid artery: appearances on colour Doppler ultrasound. (1997) (24)
- Clinical risk–benefit assessment of dopamine agonists (2008) (24)
- Subcutaneous apomorphine for parkinsonian patients with psychiatric side effects on oral treatment. (1991) (24)
- Parkinson's disease and vision (2013) (24)
- Potential of animal models for advancing the understanding and treatment of pain in Parkinson's disease. (2020) (23)
- Unexplained lower limb pain in Parkinson's disease: a phenotypic variant of "painful Parkinson's disease". (2014) (23)
- The relationship between blood flow and pulsatility index in the superior mesenteric artery at rest and during constrictor stimuli in normal subjects (1994) (23)
- Non motor symptoms in progressive supranuclear palsy: prevalence and severity (2017) (23)
- Beneficial effects of bilateral subthalamic stimulation on alexithymia in Parkinson's disease (2018) (23)
- Application of the '5-2-1' screening criteria in advanced Parkinson's disease: interim analysis of DUOGLOBE. (2020) (23)
- Review of quality of life instruments for the restless legs syndrome/Willis-Ekbom Disease (RLS/WED): critique and recommendations. (2014) (23)
- The frequency and significance of 'striatal toe' in parkinsonism. (2002) (23)
- Can therapeutic strategies prevent and manage dyskinesia in Parkinson’s disease? An update (2019) (22)
- The Long-Term Impact of Levodopa/Carbidopa Intestinal Gel on ‘Off’-time in Patients with Advanced Parkinson’s Disease: A Systematic Review (2021) (22)
- Parkinson's disease misdiagnosed as multiple system atrophy by sphincter electromyography (2000) (22)
- Analysis of four scales for global severity evaluation in Parkinson’s disease (2016) (22)
- Exploring hyperhidrosis and related thermoregulatory symptoms as a possible clinical identifier for the dysautonomic subtype of Parkinson’s disease (2019) (22)
- The moving ear syndrome: a focal dyskinesia. (1996) (22)
- Metformin as a Potential Neuroprotective Agent in Prodromal Parkinson's Disease—Viewpoint (2020) (22)
- Influence of probiotic bacteria on gut microbiota composition and gut wall function in an in-vitro model in patients with Parkinson's disease (2021) (22)
- Sustained striatal dopamine levels following intestinal levodopa infusions in Parkinson's disease patients (2017) (21)
- Phenotypic and neuropathologic heterogeneity of anti-Hu antibody-related paraneoplastic syndrome presenting with progressive dysautonomia: report of two cases (2001) (21)
- The impact of deep brain stimulation on the nonmotor symptoms of Parkinson’s disease (2013) (21)
- The efficacy of apomorphine - A non-motor perspective. (2016) (21)
- Restless legs syndrome: diagnosis and review of management options (2006) (21)
- Constipation is not associated with dopamine transporter pathology in early drug‐naïve patients with Parkinson's disease (2018) (21)
- Impact of ethnicity on the natural history of Parkinson disease (2018) (21)
- Clinical Determinants of Parkinson's Disease‐associated Pain Using the King's Parkinson's Disease Pain Scale (2017) (21)
- Repetitive belching, aerophagia, and torticollis in Huntington's disease: A case report (1998) (21)
- Thinking about motor fluctuations: An examination of metacognitions in Parkinson's disease. (2015) (21)
- Pilot Study of the International Parkinson and Movement Disorder Society‐sponsored Non‐motor Rating Scale (MDS‐NMS) (2019) (21)
- Non-motor symptoms in Parkinson's disease: An underdiagnosed problem (2006) (20)
- Nonmotor Symptoms in Experimental Models of Parkinson's Disease. (2017) (20)
- Multimodal analysis of gene expression from postmortem brains and blood identifies synaptic vesicle trafficking genes to be associated with Parkinson's disease (2020) (20)
- The Possible Clinical Predictors of Fatigue in Parkinson's Disease: A Study of 135 Patients as Part of International Nonmotor Scale Validation Project (2011) (20)
- Beneficial nonmotor effects of subthalamic and pallidal neurostimulation in Parkinson’s disease (2020) (20)
- Quantitative demonstration of the efficacy of night-time apomorphine infusion to treat nocturnal hypokinesia in Parkinson's disease using wearable sensors. (2016) (20)
- Non-Motor Symptoms Assessed by Non-Motor Symptoms Questionnaire and Non-Motor Symptoms Scale in Parkinson's Disease in Selected Asian Populations (2017) (20)
- Constipation is Associated with Development of Cognitive Impairment in de novo Parkinson's Disease: A Longitudinal Analysis of Two International Cohorts. (2021) (20)
- Noninvasive options for 'wearing-off' in Parkinson's disease: a clinical consensus from a panel of UK Parkinson's disease specialists. (2018) (20)
- Progression of nonmotor symptoms in subgroups of patients with non–dopamine‐deficient Parkinsonism (2016) (20)
- Biomarkers of Parkinson's Disease: An Introduction. (2017) (20)
- Changes in the non-motor symptom scale in Parkinson’s disease after deep brain stimulation (2011) (20)
- Effects of oral alcohol on superior mesenteric artery blood flow in normal man, horizontal and tilted. (1993) (20)
- The Parkinson disease pain classification system: results from an international mechanism-based classification approach (2020) (19)
- Unmet needs in Parkinson's disease: New horizons in a changing landscape. (2016) (19)
- Unobtrusive detection of Parkinson’s disease from multi-modal and in-the-wild sensor data using deep learning techniques (2020) (19)
- Apomorphine therapy in Parkinson's and future directions. (2016) (19)
- The cost-effectiveness of levodopa/carbidopa intestinal gel compared to standard care in advanced Parkinson’s disease (2017) (19)
- Psychometric Properties of a Generic, Patient-Centred Palliative Care Outcome Measure of Symptom Burden for People with Progressive Long Term Neurological Conditions (2016) (19)
- Transdermal rotigotine: a new non-ergot dopamine agonist for the treatment of Parkinson’s disease (2007) (19)
- Management Recommendations on Sleep Disturbance of Patients with Parkinson's Disease (2018) (18)
- Long-term safety and efficacy of apomorphine infusion in Parkinson's disease patients with persistent motor fluctuations: Results of the open-label phase of the TOLEDO study. (2021) (18)
- Nonmotor Subtyping in Parkinson's Disease. (2017) (18)
- REM sleep behavior disorder and the risk of developing Parkinson disease or dementia (2009) (18)
- Rotigotine Transdermal Patch for Motor and Non-motor Parkinson’s Disease: A Review of 12 Years’ Clinical Experience (2021) (18)
- Associations between Severity of Motor Function and Nonmotor Symptoms in Parkinson's Disease: A Post Hoc Analysis of the RECOVER Study (2014) (18)
- Adult moyamoya disease. (1993) (18)
- P1.229 Improvement of motor and non-motor symptoms after switching from oral therapy to continuous duodenal levodopa infusion in advanced Parkinson's disease (2009) (18)
- Prevalence of Non‐Motor Symptoms and Non‐Motor Fluctuations in Parkinson's Disease Using the MDS‐NMS (2020) (18)
- Proton magnetic resonance spectroscopy of the striatum in Parkinson's disease patients with motor response fluctuations. (1996) (18)
- Assessment of real life eating difficulties in Parkinson’s disease patients by measuring plate to mouth movement elongation with inertial sensors (2021) (18)
- Rotigotine transdermal system for the management of motor function and sleep disturbances in Parkinson’s disease: Results from a 1-year, open-label extension of the RECOVER study (2012) (18)
- Screening of Parkinsonian subtle fine-motor impairment from touchscreen typing via deep learning (2020) (17)
- Serum prolactin levels in Parkinson's disease and multiple system atrophy (2002) (17)
- Burden of non‐motor symptoms in Parkinson's disease patients predicts improvement in quality of life during treatment with levodopa‐carbidopa intestinal gel (2018) (17)
- Observations on haematological and cardiovascular effects of erythropoietin treatment in multiple system atrophy with sympathetic failure: a case report (2002) (17)
- Dementia in long-term Parkinson’s disease patients: a multicentre retrospective study (2020) (17)
- Levodopa–carbidopa intestinal gel in a subgroup of patients with dyskinesia at baseline from the GLORIA Registry (2018) (17)
- The effect of captopril on the superior mesenteric artery and portal venous blood flow in normal man. (1993) (17)
- Myasthenia gravis--a rare presentation with tongue atrophy and fasciculation. (2006) (17)
- Rotigotine transdermal patch and sleep in Parkinson’s disease: where are we now? (2017) (16)
- 1.060 SLEEP REGULATORY CENTRES DYSFUNCTION IN PARKINSON'S DISEASE PATIENTS WITH EXCESSIVE DAYTIME SLEEPINESS. AN IN VIVO PET STUDY (2012) (16)
- Validation of a self‐completed Dystonia Non‐Motor Symptoms Questionnaire (2019) (16)
- Non-motor predictors of 36-month quality of life after subthalamic stimulation in Parkinson disease (2021) (16)
- Debrisoquine hydroxylase gene polymorphism in Parkinson's disease and amyotrophic lateral sclerosis. (1995) (16)
- Study of EEGs following 24-hour sleep deprivation in patients with posttraumatic epilepsy. (1992) (16)
- The Parkinson's Disease Composite Scale: results of the first validation study (2018) (16)
- An imaging study of parkinsonism among African‐Caribbean and Indian London communities (2002) (15)
- Pain in the neurodegenerating brain: insights into pharmacotherapy for Alzheimer disease and Parkinson disease (2020) (15)
- Treatment of Nonmotor Symptoms in Parkinson's Disease. (2017) (15)
- Daytime apomorphine infusion combined with transdermal Rotigotine patch therapy is tolerated at 2 years: A 24-h treatment option in Parkinson's disease (2013) (15)
- Handbook of Non-Motor Symptoms in Parkinson's Disease (2012) (15)
- Personalised Advanced Therapies in Parkinson’s Disease: The Role of Non-Motor Symptoms Profile (2021) (15)
- Effectiveness and safety of opicapone in Parkinson’s disease patients with motor fluctuations: the OPTIPARK open-label study (2020) (15)
- A review of current treatment strategies for restless legs syndrome (Willis-Ekbom disease). (2014) (15)
- Magnetic resonance spectroscopic study of parkinsonism related to boxing. (1995) (15)
- Sleep dysfunction and role of dysautonomia in Parkinson's disease. (2009) (15)
- Use of the dopamine agonist cabergoline in the treatment of movement disorders (2002) (14)
- Identifying barriers to help-seeking for non-motor symptoms in people with Parkinson’s disease (2019) (14)
- Neurogenic and anti-inflammatory effects of probiotics in Parkinson’s disease: A systematic review of preclinical and clinical evidence (2021) (14)
- Managing impulse control behaviours in Parkinson's disease: practical guidelines. (2013) (14)
- First comprehensive tool for screening pain in Parkinson's disease: the King's Parkinson's Disease Pain Questionnaire (2018) (14)
- An objective measure combining physical and cognitive fatigability: Correlation with subjective fatigue in Parkinson's disease. (2016) (14)
- Restless legs syndrome (RLS), Parkinson's disease, and sustained dopaminergic therapy for RLS. (2002) (14)
- Effect of Short-term Integrated Palliative Care on Patient-Reported Outcomes Among Patients Severely Affected With Long-term Neurological Conditions (2020) (14)
- Nonmotor Parkinson's and Future Directions. (2017) (14)
- The basis for day and night-time control of symptoms of Parkinson's disease. (2002) (14)
- Subthalamic Stimulation Improves Quality of Sleep in Parkinson Disease: A 36-Month Controlled Study. (2020) (14)
- A Dual Centre Study of Pain in Parkinson's Disease and Its Relationship with Other Non-Motor Symptoms. (2020) (14)
- Comparative audit of pergolide and cabergoline therapy in the treatment of nocturnal 'off' periods causing sleep disruption in Parkinson's disease (2001) (13)
- Erratum: A proposal for a comprehensive grading of Parkinson's disease severity combining motor and non-motor assessments: Meeting an unmet need (PLoS ONE (2013) 8: 2 (e57221) DOI: 10.1371/journal.pone.0057221) (2016) (13)
- Cross-sectional analysis of the Parkinson’s disease Non-motor International Longitudinal Study baseline non-motor characteristics, geographical distribution and impact on quality of life (2021) (13)
- Differential responses in superior mesenteric artery blood flow may explain the variant pressor responses to clonidine in two groups with sympathetic denervation. (1992) (13)
- The dopaminergic basis of sleep dysfunction and non motor symptoms of Parkinson's disease: Evidence from functional imaging (2009) (13)
- Comparative audit of pergolide and cabergoline therapy in the treatment of nocturnal 'off' periods causing sleep disruption in Parkinson's disease (2001) (13)
- Improving the Delivery of Levodopa in Parkinson’s Disease: A Review of Approved and Emerging Therapies (2020) (13)
- Relationship of Nocturnal Sleep Dysfunction and Pain Subtypes in Parkinson's Disease (2018) (13)
- An overview of pain in Parkinson's disease (2016) (13)
- Impulse control and related behaviors in Parkinson’s disease with dementia (2020) (12)
- Clinical Non-Motor Phenotyping of Black and Asian Minority Ethnic Compared to White Individuals with Parkinson's Disease Living in the United Kingdom. (2020) (12)
- A Pilot Prospective, Multicenter Observational Study of Dopamine Agonist Withdrawal Syndrome in Parkinson's Disease (2015) (12)
- Dopamine agonist switching in Parkinson's disease. (2004) (12)
- Scaling-up Health-Arts Programmes: the largest study in the world bringing arts-based mental health interventions into a national health service (2020) (12)
- Nonmotor Symptoms of Parkinson's Disease (2012) (12)
- Non-motor correlates of wrist-worn wearable sensor use in Parkinson’s disease: an exploratory analysis (2019) (12)
- Genetic aspects of restless legs syndrome (2006) (12)
- Palliative Care for Patients and Families With Parkinson's Disease. (2017) (12)
- Changes in Parkinson’s disease sleep symptoms and daytime somnolence after bilateral subthalamic deep brain stimulation in Parkinson’s disease (2018) (12)
- Serum Uric Acid Levels and Non-Motor Symptoms in Parkinson's Disease. (2020) (12)
- Effectiveness and safety of opicapone in Parkinson’s disease patients with motor fluctuations: the OPTIPARK open-label study (2020) (12)
- Opicapone and Levodopa-Carbidopa Intestinal Gel Infusion: The Way Forward Towards Cost Savings for the Healthcare Systems? (2020) (11)
- Value of non-invasive continuous blood pressure monitoring in the detection of carotid sinus hypersensitivity (1991) (11)
- The impact of COVID-19 on palliative care for people with Parkinson’s and response to future pandemics (2021) (11)
- Morning Akinesia and the Potential Role of Gastroparesis – Managing Delayed Onset of First Daily Dose of Oral Levodopa in Patients with Parkinson’s Disease (2013) (11)
- Contractile dysfunction and nitrergic dysregulation in small intestine of a primate model of Parkinson’s disease (2019) (11)
- DUOGLOBE: One‐Year Outcomes in a Real‐World Study of Levodopa Carbidopa Intestinal Gel for Parkinson's Disease (2021) (11)
- Dementia in long-term Parkinson's disease patients: a multicentre retrospective study. (2020) (11)
- Author Correction: Using a smartphone-based self-management platform to support medication adherence and clinical consultation in Parkinson’s disease (2017) (11)
- Neuropsychiatric and Cognitive Changes in Parkinson's Disease and Related Movement Disorders: Diagnosis and Management (2013) (11)
- Stress and cortisol in Parkinson's disease. (2020) (10)
- Slave to the rhythm: Seasonal differences in non-motor symptoms in Parkinson's disease. (2019) (10)
- Parkinson’s Disease Detection Based on Running Speech Data From Phone Calls (2021) (10)
- Handbook of Movement Disorders (2011) (10)
- Non-motor complications in late stage Parkinson’s disease: recognition, management and unmet needs (2021) (10)
- Guide to Assessment Scales in Parkinson's Disease (2014) (10)
- Diagnostic accuracy of keystroke dynamics as digital biomarkers for fine motor decline in neuropsychiatric disorders: a systematic review and meta-analysis (2022) (10)
- Digital health technology for non-motor symptoms in people with Parkinson's disease: Futile or future? (2021) (10)
- Early Parkinson’s Disease Detection via Touchscreen Typing Analysis using Convolutional Neural Networks (2019) (10)
- Altered detrusor contractility in MPTP-treated common marmosets with bladder hyperreflexia (2017) (10)
- Active and healthy ageing for Parkinson's disease patients' support: A user's perspective within the i-PROGNOSIS framework (2016) (10)
- Intraindividual Variability of Nonmotor Fluctuations in Advanced Parkinson's Disease. (2015) (10)
- How Time Rules: Diurnal Motor Patterns in de novo Parkinson's Disease. (2021) (10)
- Expression of beta-adrenoceptors on circulating mononuclear cells in hypertensives and normotensives before and after reduction of central sympathetic outflow by clonidine. (1994) (10)
- Self‐Assessment of Disability in Parkinson's Disease: The MDS‐UPDRS Part II Versus Clinician‐Based Ratings (2017) (9)
- Palliative Care and Nonmotor Symptoms in Parkinson's Disease and Parkinsonism. (2017) (9)
- Urinary dysfunction in early de novo patients with Parkinson's disease (2017) (9)
- Mind the gap: Inequalities in mental health care and lack of social support in Parkinson disease. (2021) (9)
- Societal Burden and Persisting Unmet Needs of Parkinson’s Disease (2019) (9)
- Access and Attitudes Toward Palliative Care Among Movement Disorders Clinicians (2021) (9)
- Coronavirus Disease 2019 and Related Parkinsonism: The Clinical Evidence Thus Far (2022) (8)
- Iron and restless legs syndrome: the story unfolds. (2006) (8)
- Therapeutic options for nocturnal problems in Parkinson’s disease and atypical parkinsonian disorders (2014) (8)
- Innovative Parkinson's Disease Patients' Motor Skills Assessment: The i-PROGNOSIS Paradigm (2020) (8)
- Neuropsychiatric and cognitive disorders in other parkinsonian disorders (2013) (8)
- Two heterozygous progranulin mutations in progressive supranuclear palsy. (2021) (8)
- Sleep disturbances and gastrointestinal dysfunction are associated with thalamic atrophy in Parkinson’s disease (2019) (8)
- A new tool to identify patients with Parkinson's disease at increased risk of dementia (2017) (8)
- Identifying Parkinson’s disease subtypes with motor and non-motor symptoms via model-based multi-partition clustering (2021) (8)
- Extensive validation study of the Parkinson's Disease Composite Scale (2019) (8)
- Use and Tolerability of Cabergoline in Young and Older People with Parkinson's Disease (2003) (8)
- The future of parkinson’s treatment – Personalised and precision medicine (2017) (8)
- Evaluation of nocturnal hypokinesia in Parkinson's disease using a novel patient/proxy questionnaire and correlations with objective monitoring. (2019) (8)
- Use and Tolerability of Cabergoline in Young and Older People with Parkinson's Disease (2003) (8)
- Multiple-Instance Learning for In-The-Wild Parkinsonian Tremor Detection (2019) (7)
- Dietary Variations in a Multiethnic Parkinson's Disease Cohort and Possible Influences on Nonmotor Aspects: A Cross-Sectional Multicentre Study (2018) (7)
- Striatal Dopaminergic Deficit and Sleep in Idiopathic Rapid Eye Movement Behaviour Disorder: An Explorative Study (2021) (7)
- Adapting to post-COVID19 research in Parkinson's disease: Lessons from a multinational experience (2020) (7)
- Implications of dopaminergic medication withdrawal in Parkinson’s disease (2021) (7)
- Hemiplegia in pregnancy due to metastatic cerebral angiosarcoma. (1994) (7)
- Vanishing white matter disease presenting as opsoclonus myoclonus syndrome in childhood--a case report and review of the literature. (2014) (7)
- PD LIFE - A prospective multi-centre longitudinal audit of Quality of Life in Parkinson's disease across the UK (2003) (7)
- Prevalence Of Non-Motor Symptoms In Parkinson’s Disease: A Systematic Review With Meta-Analysis (P2.053) (2014) (7)
- Can we improve the holistic assessment of Parkinson's disease? The development of a non-motor symptom questionnaire and scale for Parkinson's disease. (2004) (7)
- European multicentre survey of tolerability rates and impulse control behaviour trends of prolonged release dopamine agonists in young and old PD (2012) (7)
- Early cognitive impairment (2013) (7)
- A study investigating the experience of working for people with Parkinson’s and the factors that influence workplace success (2018) (7)
- A noninterventional study evaluating the effectiveness of rotigotine and levodopa combination therapy in younger versus older patients with Parkinson’s disease (2018) (7)
- Implicit Theory Manipulations Affecting Efficacy of a Smartphone Application Aiding Speech Therapy for Parkinson's Patients (2012) (6)
- Smartwatch-based Activity Analysis During Sleep for Early Parkinson’s Disease Detection (2020) (6)
- Subcutaneous, intranasal and transdermal dopamine agonists in the management of Parkinson's disease (2016) (6)
- Successful Treatment of Levodopa/Carbidopa Intestinal Gel Associated “Biphasic‐like” Dyskinesia with Pallidal Deep Brain Stimulation (2020) (6)
- Evaluation of the effect of bilateral subthalamic nucleus deep brain stimulation on fatigue in Parkinson's Disease as measured by the non-motor symptoms scale. (2021) (6)
- Thermal thresholds and motor sensory conduction measurements in Guillain Barré syndrome: 12-month follow-up study. (1992) (6)
- Is EEG useful in the differential diagnosis of parkinsonism? (1998) (6)
- Two hundred years since James Parkinson's essay on the shaking palsy—Have we made progress? Insights from the James Parkinson's 200 years course held in London, March 2017 (2017) (6)
- Tolerability of non-ergot oral and transdermal dopamine agonists in younger and older Parkinson’s disease patients: an European multicentre survey (2020) (6)
- Movement Disorders Curricula (2017) (6)
- Cost-Effectiveness of Device-Aided Therapies in Parkinson’s Disease: A Structured Review (2020) (6)
- P2.149 Efflcacy of apomorphine infusion on mood and depression aspects of non-motor symptoms in advanced Parkinson's disease (2009) (6)
- Genome‐Wide Association Study of Pain in Parkinson's Disease Implicates TRPM8 as a Risk Factor (2020) (6)
- Self-reported periodontitis and C-reactive protein in Parkinson’s disease: a cross-sectional study of two American cohorts (2022) (6)
- Human immunodeficiency virus‐related progressive multifocal leukoencephalopathy presenting with an akinetic rigid syndrome (1996) (6)
- Predictors of short-term impulsive and compulsive behaviour after subthalamic stimulation in Parkinson disease (2021) (6)
- Functional Neurological Disorders and COVID‐19 Vaccination (2021) (5)
- Exploring Bedroom Usability and Accessibility in Parkinson’s Disease (PD): The Utility of a PD Home Safety Questionnaire and Implications for Adaptations (2018) (5)
- Progression and biomarkers for Parkinson disease (2016) (5)
- Sleep and Quality of Life in Parkinson’s Disease (2008) (5)
- Movement Disorders in Clinical Practice (2010) (5)
- Emotional well-being and pain could be a greater determinant of quality of life compared to motor severity in cervical dystonia (2020) (5)
- Effect of Short-term Integrated Palliative Care on Patient-Reported Outcomes Among Patients Severely Affected With Long-term Neurological Conditions A Randomized Clinical Trial (2020) (5)
- Does Ethnicity Influence Recruitment into Clinical Trials of Parkinson's Disease? (2022) (5)
- Opicapone versus placebo in the treatment of Parkinson’s disease patients with end-of-dose motor fluctuation-associated pain: rationale and design of the randomised, double-blind OCEAN (OpiCapone Effect on motor fluctuations and pAiN) trial (2022) (5)
- TREATMENT OF PARKINSON'S DISEASE AND RESTLESS LEGS SYNDROME WITH CABERGOLINE, A LONG‐ACTING DOPAMINE AGONIST (2002) (5)
- Depression, anxiety and PTSD symptoms before and during the COVID-19 pandemic in the UK. (2021) (5)
- Thirty years of research on autonomic dysfunction, non-motor features, and endophenotypes in Parkinson disease (2021) (5)
- Gender gap in deep brain stimulation for Parkinson’s disease (2022) (5)
- Octreotide reduces alcohol-induced hypotension and orthostatic symptoms in primary autonomic failure. (1995) (5)
- Advance Care Planning and Care Coordination for People With Parkinson's Disease and Their Family Caregivers—Study Protocol for a Multicentre, Randomized Controlled Trial (2021) (5)
- Predicting the risk of stroke in patients with late-onset epilepsy: A machine learning approach (2021) (5)
- Author Correction: Parkinson disease-associated cognitive impairment (2021) (5)
- Impulse control disorders are associated with lower ventral striatum dopamine D3 receptor availability in Parkinson's disease: A [11C]-PHNO PET study. (2021) (5)
- Evaluation of the use of a dystonia non motor symptom questionnaire for craniocervical dystonia in the outpatient clinic (2014) (4)
- International validation of the first united non motor symptoms scale for Parkinson's disease. Results from the first pilot NMSS study (2006) (4)
- Treatment and identification of restless legs syndrome (2008) (4)
- ‘Dopamine agonist Phobia’ in Parkinson’s disease: when does it matter? Implications for non-motor symptoms and personalized medicine (2020) (4)
- Sialorrhoea in Parkinson’s disease (2009) (4)
- Pain in Parkinson's disease: Mechanism-based treatment strategies. (2021) (4)
- Phenomenology of Levodopa-Induced Dyskinesia (2014) (4)
- Applications of the European Parkinson’s Disease Association sponsored Parkinson’s Disease Composite Scale (PDCS) (2019) (4)
- The debate of motor versus non-motor aspects of Parkinson’s disease: Time for marriage (2011) (4)
- Pain in Parkinson's disease: Mechanism-based treatment strategies. (2021) (4)
- The Effect of Non-motor Symptoms on Quality of Life in Parkinson’s Disease (2009) (4)
- Quality of Life Scales (2014) (4)
- Comprar Non-Motor Symptoms Complex of Parkinson's Disease | Anthony Schapira | 9780199237234 | Oxford University Press (2009) (4)
- Effects of safinamide on pain in patients with fluctuating Parkinson's disease (2021) (4)
- Restless legs syndrome - the under-recognised non-motor burden: a questionnaire-based cohort study (2019) (4)
- Sweating and other thermoregulatory abnormalities in Parkinson’s disease: A review (2019) (4)
- Factor Analysis and Clustering of the Movement Disorder Society–Non‐Motor Rating Scale (2020) (4)
- Covid-19 and Parkinson's disease: Acute clinical implications, long-COVID and post-COVID-19 parkinsonism (2022) (4)
- Advances in the pharmacological and non-pharmacological management of non-motor symptoms in Parkinson's disease: an update since 2017. (2022) (4)
- Parkinson's disease misdiagnosed as multiple system atrophy by sphincter electro-myography. (2000) (4)
- Parkinson’s Disease: Personalized Pathway of Care for Device-Aided Therapies (DAT) and the Role of Continuous Objective Monitoring (COM) Using Wearable Sensors (2021) (4)
- Ophthalmological aspects of Parkinson’s disease (2009) (4)
- Plasma p-tau181, neurofilament light chain and association with cognition in Parkinson’s disease (2022) (4)
- Restricted truncal sagittal movements of rapid eye movement behaviour disorder (2022) (4)
- Safinamide in the treatment pathway of Parkinson’s Disease: a European Delphi Consensus (2022) (4)
- Twenty Years of Apomorphine Therapy - How Does it Compare with Levodopa? Highlights of a Satellite Symposium Held at the 18th International Congress of Parkinson's Disease and Movement Disorders, Stockholm, 8-12 June 2014 (2014) (3)
- Management of dysphagia and gastroparesis in Parkinson’s disease in real-world clinical practice – Balancing pharmacological and non-pharmacological approaches (2022) (3)
- The New Satisfaction with Life and Treatment Scale (SLTS-7) in Patients with Parkinson's Disease. (2021) (3)
- How far are we in understanding the cause of Parkinson's disease? (1997) (3)
- The First Parkinson's Disease Pain Questionnaire (King's PD Pain Quest) – an interim analysis of a multicentre study of the patient's perspective (2016) (3)
- IV.P11 Subthalamic nucleus (STN) deep brain stimulation (DBS) and the non-motor symptom scale (NMSS) in Parkinson's Disease (PD) (2006) (3)
- Sustained and Prolonged Striatal Dopamine Levels in Parkinson's Patients Following Enteral L-Dopa Gel Infusion: An In Vivo 11C-Raclopride PET Study (2013) (3)
- P2.170 Effect of rotigotine on control of early morning motor function and sleep quality in subjects with idiopathic Parkinson's disease (2009) (3)
- Does the 5–2-1 criteria identify patients with advanced Parkinson's disease? Real-world screening accuracy and burden of 5–2-1-positive patients in 7 countries (2022) (3)
- Early morning off periods in Parkinson's disease: Characterisation of non motor patterns and treatment effect: An international study (2012) (3)
- Usefulness of Parkinson's KinetiGraph in a Parkinson's disease clinic – Survey of 82 patients (2016) (3)
- Restless Legs Syndrome: A Review of Diagnosis and Management (2006) (3)
- What are the non-motor symptoms of Parkinson’s disease? (2009) (3)
- Parkinsonism and other extrapyramidal diseases (2010) (3)
- New approaches to treatments for sleep, pain and autonomic failure in Parkinson's disease - Pharmacological therapies (2022) (3)
- Patterns of treatment for restless legs syndrome in primary care in the United Kingdom. (2008) (3)
- Viruses, parkinsonism and Parkinson’s disease: the past, present and future (2022) (3)
- Magnetic Resonance Parkinsonism Index Is Associated with REM Sleep Behavior Disorder in Parkinson’s Disease (2022) (2)
- Immediate versus delayed short-term integrated palliative care for advanced long-term neurological conditions: the OPTCARE Neuro RCT (2020) (2)
- Editorial: Movement Disorders and Sleep – Underlying Mechanisms, Clinical Aspects and Treatment (2019) (2)
- Reply to: “Concerns Raised by Publication of Antonini et al., ‘Outcome of Parkinson Disease Patients Affected by Covid‐19’” (2020) (2)
- Establishing apomorphine treatment in Thailand: understanding the challenges and opportunities of Parkinson’s disease management in developing countries (2020) (2)
- The Non Motor Staging of Parkinson's Disease: Results from an International Study (2009) (2)
- Wellness, sexual health, and nonmotor Parkinson's. (2022) (2)
- 2.258 LONG ACTING DOPAMINE AGONISTS IN CLINICAL PRACTICE: A COMPARATIVE MULTICENTRE EUROPEAN SURVEY IN YOUNG AND OLD PD (2012) (2)
- New perspectives in non-oral drug delivery in Parkinson's disease: Highlights of a satellite symposium held at the XX world congress on Parkinson's disease and related disorders, Geneva, Switzerland, 8-11 December 2013 (2014) (2)
- Oropharyngeal dysphagia in Parkinson's disease: comments on paper by Kalf et al. (2013) (2)
- P2.150 Ropinirole prolonged release improves nocturnal symptoms in patients with advanced Parkinson's disease: an analysis of individual items on the PDSS (2009) (2)
- Gender-related differences in the burden of non-motor symptoms in Parkinson's disease Pablo Martinez-MartinCristian Falup PecurariuPer OdinJacobus J. van Hilten • Angelo AntoniniJose M. Rojo-AbuinVanderci BorgesClaudia Trenkwalder • Dag AarslandDavid J. BrooksKallol Ray Chaudhuri (2012) (2)
- Central defects of autonomic function in secondary progressive multiple sclerosis: observations based on cardiovascular and growth hormone responses to clonidine (1995) (2)
- I.P2 Prevalence of non motor symptoms in Parkinson's Disease: An international survey using NMSQuest in 525 patients (2006) (2)
- The Non-motor Parkinson’s Disease (2017) (2)
- Pain in Parkinson's disease: Observational study of 225 patients (2011) (2)
- Psychometric Properties of Clinical Indicators for Identification and Management of Advanced Parkinson’s Disease: Real-World Evidence From G7 Countries (2022) (2)
- Extending our Understanding of the Dopaminergic Basis of Non-motor Symptoms in Parkinson's Disease Highlights of a Britannia symposium held at the 10th International Congress on Non-Motor Dysfunctions in Parkinson's Disease and Related Disorders, 5th December 2014, Nice, France (2015) (2)
- Impulse control dysfunction and dopamine agonist withdrawal syndrome in Genetic Parkinson’s: A case report (2015) (2)
- Comparative Effectiveness of Device-Aided Therapies on Quality of Life and Off-Time in Advanced Parkinson’s Disease: A Systematic Review and Bayesian Network Meta-analysis (2022) (2)
- Superior mesenteric artery vascular resistance is higher in hypertensives and is lowered by clonidine. (1991) (2)
- Outcomes Impacting Quality of Life in Advanced Parkinson’s Disease Patients Treated with Levodopa-Carbidopa Intestinal Gel (2021) (2)
- Selecting patients for continuous dopaminergic stimulation therapy (2011) (2)
- Health‐related quality of life in Asian and other ethnic groups with Parkinson’s disease (2008) (2)
- Neurological research & training after the easing of lockdown in countries impacted by COVID-19 (2020) (2)
- Global Long-term Registry on Efficacy and Safety of Levodopa-Carbidopa Intestinal Gel in Patients with Advanced Parkinson’s Disease in Routine Care (GLORIA) - Interim Results in a Subgroup of Patients with Dyskinesia at Baseline (P1.192) (2015) (2)
- Tolerability of overnight rotigotine transdermal patch combined with intrajejunal levodopa infusion at 1 year: a 24-h treatment option in Parkinson’s disease (2022) (2)
- Comprar Movement Disorders Curricula | Cristian Falup-Pecurariu | 9783709116272 | Springer (2017) (2)
- 2.135 CHARACTERISING NON MOTOR PATTERNS OF EARLY MORNING OFF PERIODS IN PARKINSON'S DISEASE: AN INTERNATIONAL STUDY (2012) (2)
- Opicapone in UK clinical practice: effectiveness, safety and cost analysis in patients with Parkinson's disease. (2022) (2)
- Intrajejunal levodopa infusion therapy for Parkinson’s disease: practical and pragmatic tips for successful maintenance of therapy (2017) (2)
- Dyskinesia Matters: But Not as Much as It Used to (2020) (2)
- Dispersed Sleep Microstates and Associated Structural Changes in GBA1 Mouse: Relevance to Rapid Eye Movement Behavior Disorder (2021) (2)
- The association between pain and impulse control behaviours in Parkinson's disease. (2020) (2)
- Neuropsychiatric and Cognitive Changes in Parkinson's Disease and Related Movement Disorders: Sleep disturbances (2013) (1)
- RENEWAL: REpurposing study to find NEW compounds with Activity for Lewy body dementia—an international Delphi consensus (2022) (1)
- Parkinson's Disease Composite Scale (2020) (1)
- P1.146 Parkinson's disease staging based of the non-motor symptoms scale (2009) (1)
- The Cost Effectiveness of Levodopa-Carbidopa Intestinal Gel in the Treatment of Advanced Parkinson’s Disease in England (2022) (1)
- General approach to patients with autonomic dysfunction in Parkinson's disease (2021) (1)
- Effects of Levodopa-Carbidopa Intestinal Gel on Dyskinesia and Non-Motor Symptoms Including Sleep: Results from a Meta-Analysis with 24-Month Follow-Up (2022) (1)
- Cognition and Neuropsychiatric Symptoms (2014) (1)
- How Do I Examine Nonmotor Aspects of Parkinson's Disease? What Not to Miss and What to Ignore? (2014) (1)
- Diplopia in Parkinson's disease: Prevalence and associations with other motor and nonmotor symptoms (2013) (1)
- The impact of nonmotor symptom burden on sexual function. (2022) (1)
- Restless Legs Syndrome: briefing (2015) (1)
- 1.144 Changes in sexual interest and function in patients with Parkinson's disease: Focus on hypersexuality (2007) (1)
- Olfaction, pain and other sensory abnormalities in Parkinson’s disease (2013) (1)
- Carpopedal Spasm as Presenting Feature of Adult Moyamoya Disease (1994) (1)
- P1.147 Gender differences in non-motor symptoms in Parkinson's disease (2009) (1)
- Ethnic Disparities in Treatment of Chronic Pain in Individuals with Parkinson's Disease Living in the United Kingdom (2022) (1)
- Relevance of sleep and associated structural changes in GBA1 mouse to human rapid eye movement behavior disorder (2022) (1)
- Physiological and Functional Changes in the Colon of MPTP-Treated Common Marmosets (2014) (1)
- Dystonia Non-Motor Symptoms Questionnaire (DNMSQuest) zur Erhebung nichtmotorischer Symptome bei Dystonie (2020) (1)
- Quantisation of soliton solution of a generalised discrete non-linear equation (1979) (1)
- Global Long-Term Registry on Efficacy and Safety of Levodopa-Carbidopa Intestinal Gel in Patients with Advanced Parkinson’s Disease in Routine Care (GLORIA) - Interim Results on Non-Motor Symptoms (I3-3B) (2015) (1)
- Nonmotor symptom burden grading as predictor of cognitive impairment in Parkinson’s disease (2021) (1)
- Medical evaluation as gold standard to control iPrognosis application derived data for early Parkinson's disease detection (2020) (1)
- Dysregulation of epithelial ion transport and neurochemical changes in the colon of a parkinsonian primate (2021) (1)
- Disentangling the PIGD classification for the prediction of cognitive impairment in de novo Parkinson’s disease (2021) (1)
- Characterization of Non‐Motor Fluctuations Using the Movement Disorder Society Non‐Motor Rating Scale (2022) (1)
- Viewpoint and practical recommendations from a movement disorder specialist panel on objective measurement in the clinical management of Parkinson’s disease (2018) (1)
- Scales for Measuring Parkinsonism in Demented Patients (2014) (1)
- [Dystonia Non-Motor Symptoms Questionnaire (DNMSQuest) for assessment of non-motor symptoms in dystonia : Intercultural adaptation in the German language]. (2020) (1)
- M-E-053 EFFECTS OF TRANSDERMAL ROTIGOTINE ON SLEEP AND NOCTURNAL SYMPTOMS OVER A 1-YEAR PERIOD IN PARKINSON'S DISEASE: AN OPEN-LABEL EXTENSION OF THE RECOVER STUDY (2011) (1)
- Editorial: Prodromal Parkinson's Disease (2021) (1)
- Effect of Apomorphine on Non-Motor Symptoms in Parkinson's Disease (2011) (1)
- Movement disorders in COVID-19 times: impact on care in movement disorders and Parkinson disease (2022) (1)
- Correction: A Proposal for a Comprehensive Grading of Parkinson's Disease Severity Combining Motor and Non-Motor Assessments: Meeting an Unmet Need (2016) (1)
- Reply to: “Parkinson disease‐associated dyskinesia in countries with low access to levodopa‐sparing Regimens“ (2019) (1)
- The real-life effect of catechol-O-methyltransferase inhibition on non-motor symptoms in levodopa-treated Parkinson's disease: opicapone versus entacapone. (2023) (1)
- Clinical trajectories and biomarkers for weight variability in early Parkinson’s disease (2022) (1)
- Psychosis in Parkinson’s Disease (2015) (1)
- International validation study of the first comprehensive unified Nonmotor Symptoms Scale (NMSS) for Parkinson's disease (PD) (2006) (1)
- Cost-effectiveness analysis of the Parkinson’s KinetiGraph and clinical assessment in the management of Parkinson's disease (2022) (1)
- Treatment of non-motor symptoms in Parkinson ’ s disease (2018) (1)
- Early factors for predicting discontinuation to subcutaneous Apomorphine infusion in Parkinson's disease: A prospective analysis of the Thai Apomorphine Registry. (2021) (1)
- The Dashboard Vitals of Parkinson’s: Not to Be Missed Yet an Unmet Need (2022) (1)
- Gastrointestinal barriers to levodopa transport and absorption in Parkinson's disease (2023) (1)
- A Patient-Centered Conceptual Model of Symptoms and Their Impact in Early Parkinson’s Disease: A Qualitative Study (2021) (1)
- Neuroanatomical substrates in Parkinson’s Disease psychosis and their association with serotonergic receptor gene expression: A coordinate-based meta-regression analysis (2022) (1)
- Keep calm and beam on? Unmet needs in radiotherapy and deep brain stimulation. (2020) (1)
- Frailty in Parkinson's disease and its association with early dementia: A longitudinal study. (2022) (1)
- CME Movement disorders (100624): self-assessment questionnaire. (2016) (0)
- Dysregulation of epithelial ion transport and neurochemical changes in the colon of a parkinsonian primate (2021) (0)
- Parkinson’s disease: pathology, anatomy, and behavior (2013) (0)
- Chapter 8 Illustrative case reports (2009) (0)
- Introducing a new journal on Parkinson’s disease (2015) (0)
- Author Correction: Using a smartphone-based self-management platform to support medication adherence and clinical consultation in Parkinson’s disease (2017) (0)
- A Long-term Study on Effectiveness of Levodopa-carbidopa Intestinal Gel Treatment in Advanced Parkinson’s Disease Patients (P5.066) (2018) (0)
- A Landmark Year for Apomorphine – Advancing Parkinson’s Disease Management with New Clinical Evidence (2017) (0)
- Non- motor staging of Parkinson's disease (PD) and early longitudinal follow up results from an international study (2009) (0)
- Chapter 4 Symptoms and health-related quality of life (2009) (0)
- Clinical Trials on Management of Pain in Parkinson’s Disease (2021) (0)
- Nocturnal movement disorders and epilepsy overlap syndromes (2004) (0)
- Restricted truncal sagittal movements of rapid eye movement behaviour disorder (2022) (0)
- FORTY-FIVE Personalized Medicine and Nonmotor Symptoms in Parkinson ’ s Disease (2017) (0)
- Smartphone sensor data (accelerometer, virtual keyboard) collected in-the-wild by Parkinson's Disease patients and Healthy Controls (2020) (0)
- P2.124 Changes in quality of life and nocturnal symptoms in sleep-impaired patients with advanced Parkinson's disease treated with ropinirole prolonged release (2009) (0)
- IV.P1 Nocturnal “wearing off” symptoms in levodopa treated Parkinson's Disease: an under-recognised phenomenon (2006) (0)
- Fatigue in Parkinson's disease and striatum dopamine transporter scan (DaTscan) uptake (2016) (0)
- The noradrenergic subtype of Parkinson disease: from animal models to clinical practice. (2023) (0)
- 12th Clinical Autonomic Research Society Meeting, the Wellcome Trust Building, London, November 1995 (1996) (0)
- Oral session 22—Motor neuron disease (2) (2005) (0)
- Iconographies supplémentaires de l'article : Vanishing White Matter Disease Presenting as Opsoclonus Myoclonus Syndrome in Childhood—A Case Report and Review of the Literature (2014) (0)
- Revisiting Alpha-Synuclein Pathways to Inflammation (2023) (0)
- Reply to: Subthalamic Nucleus Deep Brain Stimulation as Rescue Therapy for Levodopa Carbidopa Intestinal Gel–Associated Biphasic‐Like Dyskinesias (2021) (0)
- Depression and Catechol-O-methyltransferase (COMT) genetic variants are associated with pain in Parkinson’s disease (2017) (0)
- Reversible acute worsening of motor and non-motor symptoms in advanced Parkinson’s disease after long distance travels (2011) (0)
- Management of Movement Disorders: The Challenge of 24-Hour Symptom Control: EFNS, Copenhagen, October 2000 (2001) (0)
- Management of bladder dysfunction in patients with multiple-system atrophy (2006) (0)
- Utilization of COMT inhibitors, dopamine agonists, and MAO-B inhibitors with levodopa-carbidopa instestinal gel in advanced Parkinson's disease patients: Summary of phase 3 and real-world studies (2019) (0)
- Parkinson's disease and Covid-19: Is there an impact of ethnicity and the need for palliative care (2022) (0)
- The Editors Words (2017) (0)
- PS02.1 Sleep disorders in Parkinson's Disease and other movement disorders (2007) (0)
- Psychiatric Aspects of Parkinsonism (2018) (0)
- Surgical problems in thyroid disease. (1946) (0)
- ‘Levodopa Phobia’: a review of a not uncommon and consequential phenomenon (2018) (0)
- Parkinson's disease severity levels and MDS-Uni fi ed Parkinson's Disease Rating Scale Parkinsonism and Related Disorders (0)
- Treatment paradigms in Parkinson's Disease and Covid-19 (2022) (0)
- Parkinson's disease and quality of life - a clinician's perspective (2011) (0)
- Bilateral subthalamic stimulation improves aspects of nonmotor symptoms in Parkinson’s disease (2014) (0)
- Contractile dysfunction and nitrergic dysregulation in small intestine of a primate model of Parkinson’s disease (2019) (0)
- Gender gap in deep brain stimulation for Parkinson’s disease (2022) (0)
- 135 Hyperhidrosis as an identifier in parkinson’s disease subtyping (2019) (0)
- Monday, 10 December 200713.00–15.00 and 17.00–18.00 Hall 3Poster PresentationsParkinsonism1.126 Non-motor symptoms in akinesia dominant versus other phenotypes in Parkinson's disease (PD): Results form the international PD non-motor symptoms scale study (2007) (0)
- Levodopa-carbidopa intestinal gel treatment in patients with <10 years of Parkinson's disease: GLORIA registry interim results (2016) (0)
- Author Correction: Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson’s disease: evidence for dopaminergic basis? (2017) (0)
- Levodopa Dose Equivalency in Parkinson's Disease: Updated Systematic Review and Proposals. (2023) (0)
- S15.C Pain and restless legs syndrome (RLS): clinical observations from 165 cases (2007) (0)
- Characterisation of Restless Legs like syndrome in Parkinson's disease (2009) (0)
- The Gut Dysmotility Questionnaire for Parkinson's disease: Insights into development and pretest studies (2023) (0)
- Distribution and impact on quality of life of the pain modalities assessed by the King’s Parkinson’s disease pain scale (2017) (0)
- Non-oral continuous drug delivery based therapies and sleep dysfunction in Parkinson's disease. (2023) (0)
- REPRINTED WITH PERMISSION OF IASP – PAIN 162 (2021) 999–1006: Pain in the neurodegenerating brain: insights into pharmacotherapy for Alzheimer disease and Parkinson disease (2021) (0)
- Non-motor Symptoms in Late-stage Parkinson’s Disease – Is Continuous Dopaminergic Stimulation Beneficial? (2008) (0)
- Applications of the European Parkinson’s Disease Association sponsored Parkinson’s Disease Composite Scale (PDCS) (2019) (0)
- Drug treatment and behavior (2013) (0)
- Clinical trajectories and biomarkers for weight variability in early Parkinson’s disease (2022) (0)
- Dysphagia, pneumonia and hospital admissions in Parkinson's Disease: a multicentre observational study (2016) (0)
- Chapter 5 Differential diagnosis of restless legs syndrome (2009) (0)
- White matter regions of fractional anisotropy changes between PSP, MSA, PD and HC. (2014) (0)
- Diffractive element in condenser for ultra-uv lithography (1999) (0)
- MATTERS ARISING (1995) (0)
- Apparatus for extreme UV lithography with a semiconductor plate chamber and a gas curtain (1999) (0)
- Proton magnetic resonance spectroscopy (1H-MRS) of putamen in schizophrenic patients with and without tardive dyskinesia (1998) (0)
- Nonmotor symptoms in patients suffering from motor neuron diseases (0)
- O.038 Continuous dopaminergic stimulation (CDS) (2009) (0)
- Spotlight on non-motor symptoms and Covid-19 (2022) (0)
- Why do ‘OFF’ periods still occur during continuous drug delivery in Parkinson’s disease? (2022) (0)
- 3.IS.3.2 Treating Parkinson's symptoms 24 hours – Day and night (2007) (0)
- P1.104 Night time eating in Parkinson's disease, a new aspect of punding? (2009) (0)
- 1.284 Daytime fatigue in idiopathic restless legs syndrome: Evaluation with Parkinson's fatigue scale (2007) (0)
- Letters to the Editor. (1997) (0)
- Theeffect ofcaptopril on thesuperior mesenteric artery and portal venousbloodflowinnormal man (1993) (0)
- Beneficial nonmotor effects of subthalamic and pallidal DBS in Parkinson's disease (2018) (0)
- The neural and hormonal control of splanchnic blood flow in normal and abnormal man. (1993) (0)
- Neural substrates in Parkinson's Disease psychosis: A systematic review (2022) (0)
- Chapter 7 Treatment of restless legs syndrome and periodic limb movement disorder (2009) (0)
- Effects of Levodopa-Carbidopa Intestinal Gel Compared with Optimized Medical Treatment on Nonmotor Symptoms in Advanced Parkinson's Disease: INSIGHTS Study (2022) (0)
- Chapter-13 Nocturnal Disabilities in Parkinsons Disease and its Management (2005) (0)
- Behavioural and Psychiatric Symptoms in Patients With Neurodegenerative Diseases (2005) (0)
- Faculty Opinions recommendation of Natural history of motor symptoms in Parkinson's disease and the long-duration response to levodopa. (2020) (0)
- 3.420 Differential effect of the Parkinson's disease non-motor symptoms on patients' health-related quality of life (2007) (0)
- Pain in neurodegenerative diseases with atypical parkinsonism: a systematic review on prevalence, clinical presentation, and findings from experimental studies. (2021) (0)
- Understanding the importance of the nocturnal symptoms of Parkinson's disease: Diagnosis, treatment, and quality of life (2004) (0)
- Assessing the non-motor symptom burden progression in a longitudinal study of 411 Parkinson's patients, using the non-motor symptom questionnaire (2016) (0)
- Disease severity in the DUOGLOBE patient population based on manage-PD section 2 domains: Interim subgroup analysis (2021) (0)
- Global improvement in patients with restless legs syndrome from a double-blind, placebo-controlled pramipexole trial (2008) (0)
- 2.253 INTRAJEJUNAL LEVODOPA INFUSION IN THE UK: COMPARATIVE REVIEW OF MOTOR AND NON-MOTOR EFFECTS IN TREATED VERSUS UNTREATED ADVANCED PARKINSON'S PATIENTS (2012) (0)
- Non-motor symptoms (nms) improvement is correlated with baseline nms burden and improved quality of life (QoL) in levodopa-carbidopa intestinal gel (LCIG) treated parkinson’s disease patients (2017) (0)
- Faculty Opinions recommendation of Brain Motor Network Changes in Parkinson's Disease: Evidence from Meta-Analytic Modeling. (2021) (0)
- The ocean (opicapone effect on motor fluctuations and associated pain) study in Parkinson's disease: Design and rationale of a randomized double-blind placebo-controlled trial (2021) (0)
- Sustained improvements in motor and non-motor symptoms in advanced Parkinson's disease patients treated with carbidopa levodopa enteral suspension in a ‘real-world’ study (2021) (0)
- on Management of Pain in Parkinson’s (2020) (0)
- 3.423 Travelling related worsening of parkinsonism in Parkinson's disease (2007) (0)
- Scales that Evaluate Specific Non-motor Disorders (2014) (0)
- Infectious basis to the pathogenesis of Parkinson's disease. (2007) (0)
- Comprar Restless Legs Syndrome | K. Ray Chaudhuri | 9780199234882 | Oxford University Press (2009) (0)
- International validation of the first non-motor questionnaire (NMSQuest) and scale (NMSS) for Parkinson's disease (2007) (0)
- First Two-Year Observational Exploratory Real Life Clinical Phenotyping, and Societal Impact Study of Parkinson’s Disease in Emiratis and Expatriate Population of United Arab Emirates 2019–2021: The EmPark Study (2022) (0)
- Restless legs syndrome in Parkinson's disease is associated with fatigue and insomnia but not daytime sleepiness: Study of 329 cases (2012) (0)
- Non-Motor Symptoms in Cervical Dystonia: A Concept in Evolution (2020) (0)
- Faculty Opinions recommendation of Safinamide Improves Non-Motor Symptoms Burden in Parkinson's Disease: An Open-Label Prospective Study. (2021) (0)
- 1.152 Dribbling of saliva in Parkinson's disease: Clinical correlations (2007) (0)
- Clinical experience with 123I β-CIT SPET imaging in atypical tremor patients (2001) (0)
- A Preliminary Investigation of the Views of People With Parkinson's (With and Without Psychosis) and Caregivers on Participating in Clinical Trials During the Covid-19 Pandemic: An Online Survey (2020) (0)
- Letter to the editor: Automated night-time deep brain stimulation battery checks can induce symptoms: Identification and management of a new hardware complication (2017) (0)
- Chapter 1 The historical basis of restless legs syndrome (2009) (0)
- Rotigotine: first dopamine agonist transdermal patch (2007) (0)
- Clinical trials for cognition in Parkinson's disease: Where are we and how can we do better? (2023) (0)
- Motor Impairment and Disability Scales (2014) (0)
- The clinical impact of COVID-19 infection on people with Parkinson's (2020) (0)
- Rotigotine transdermal patch and sleep in Parkinson’s disease: where are we now? (2017) (0)
- NMS in PD: Dopaminergic and Nondopaminergic (2014) (0)
- B.1 The non-motor symptom complex of Parkinson's Disease: The Questionnaire and Scale Development Program (2006) (0)
- Multi-Modal Analysis of Gene Expression from Postmortem Brains and Blood Identifies Synaptic Vesicle Trafficking Genes to Be Associated with Parkinson's Disease (2020) (0)
- White matter maps showing regions of significant decreased fractional anisotropy and increased mean diffusivity in MSA patients when compared to healthy controls and PD (Bonferroni corrected alpha = 0.0167). (2014) (0)
- Non-motor correlates of wrist-worn wearable sensor use in Parkinson’s disease: an exploratory analysis (2019) (0)
- Author response for "Nonmotor symptom burden grading as predictor of cognitive impairment in Parkinson’s disease" (2020) (0)
- Pramipexole: A Viewpoint by Sharon Muzerengi and K. Ray Chaudhuri (2007) (0)
- Non-Motor Symptoms Questionnaire (2021) (0)
- 1.014 Non-motor symptoms in akinesia dominant versus other phenotypes in Parkinson's disease (PD): Results from the international PD non-motor symptoms scale study (2007) (0)
- Sustained Dopamine Agonism with Cabergoline in Parkinson’s Disease (2002) (0)
- Non-motor effects of deep brain stimulation in Parkinson's disease motor subtypes. (2023) (0)
- Surgical Treatment of Parkinson’s Disease, Transplantations and Restorative Therapies for Parkinson’s Diseases (2017) (0)
- Levodopa-carbidopa intestinal gel treatment of motor fluctuations and dyskinesia in advanced Parkinson’s disease patients in a ‘real world’ setting: Interim results from the DUOGLOBE study (2019) (0)
- 15th Annual Scientific Meeting of the Clinical Autonomic Research Society (2005) (0)
- A scoping review of neurodegenerative manifestations in explainable digital phenotyping (2023) (0)
- Using a smartphone-based self-management platform to support medication adherence and clinical consultation in Parkinson’s disease (2017) (0)
- Comprehensive Non-motor Symptoms Assessments (2014) (0)
- Dystonia Non-Motor Symptoms Questionnaire--German Version (2020) (0)
- Chapter 2 Parkinsonian syndromes (2018) (0)
- I.9 Sleep disorders in Parkinson's Disease (2006) (0)
- Non motor symptoms in progressive supranuclear palsy: prevalence and severity (2017) (0)
- The pathophysiology of sexual dysfunction in Parkinson's disease: An overview. (2022) (0)
- Changes in Parkinson’s disease sleep symptoms and daytime somnolence after bilateral subthalamic deep brain stimulation in Parkinson’s disease (2018) (0)
- FM2-3 Slave to the rhythm: seasonal differences in non-motor symptoms in parkinson’s (2019) (0)
- Career mentorship for young neurologists in Europe (2012) (0)
- PICS Gambling scale (2016) (0)
- The Impact of a Digital Artificial Intelligence System on the Monitoring and Self-management of Nonmotor Symptoms in People With Parkinson Disease: Proposal for a Phase 1 Implementation Study (2022) (0)
- Faculty Opinions recommendation of The inconsistency and instability of Parkinson's disease motor subtypes. (2021) (0)
- Plasma Neurofilament Light and p-tau181 and Risk of Psychosis in Parkinson's Disease. (2022) (0)
- The Non-Motor Symptoms Questionnaire and Non-Motor Symptoms Scale for use in Sweden (2017) (0)
- Hiccups, Hypersalivation, Hallucinations in Parkinson’s Disease: New Insights, Mechanisms, Pathophysiology, and Management (2023) (0)
- Multi-domain Scales (2014) (0)
- The treatment challenges of restless legs syndrome (2016) (0)
- Rationale and Design of an Open-Label, Randomized, 26-Week Study Comparing Levodopa-Carbidopa Intestinal Gel to Optimized Medical Treatment on Non-Motor Symptoms in Patients with Advanced Parkinson’s Disease – INSIGHTS Study (P2.048) (2018) (0)
- The lack of Ambulation in REM sleep Behaviour disorder - Why do they stay in bed? (2022) (0)
- Reply to Comment on: Successful Treatment of Levodopa/Carbidopa Intestinal Gel Associated “Biphasic‐Like” Dyskinesia with Pallidal Deep Brain Stimulation (2021) (0)
- Development of an online intervention to increase help-seeking in Parkinson’s disease (2016) (0)
- Medical follow up assessments of iPrognosis application users for early Parkinson's disease detection (2020) (0)
- Apomorphine infusion for improving sleep in Parkinson's disease (2022) (0)
- Non-motor symptoms may herald Parkinson’s disease (2017) (0)
- Non-motor Symptoms (NMS) Improvement is Positively Correlated with Baseline NMS Burden and Improved Quality of Life in Advanced Parkinson’s Disease Patients Treated with Levodopa-carbidopa Intestinal Gel: A Post-hoc Analysis from the GLORIA Registry (P1.038) (2018) (0)
- 2 Evaluation of the Patient with Parkinson ’ s Disease in the Early Stages: Non-Motor Phase (2022) (0)
- O.055 The autonomic nervous system and sleep disorders in Parkinson's disease (2009) (0)
- A review of clinical management of Restless Legs Syndrome (2008) (0)
- Non-motor predictors of 36-month quality of life after subthalamic stimulation in Parkinson disease (2021) (0)
- On behalf of the International Parkinson's Disese Non-Motor Symptom Scale Development Group. Can we improve the holistic assessment of Parkinson's disease? The development of a non-motor symptom questionnaire adn scale for PD: (2004) (0)
- Therapy in Practice: Assessment and Management of Neuropsychiatric Symptoms in Parkinson’s Disease (0)
- Assessment of real life eating difficulties in Parkinson’s disease patients by measuring plate to mouth movement elongation with inertial sensors (2021) (0)
- PANDA: Prolonged release oxycodone/naloxone (OXN PR) for severe Parkinson’s disease (PD)-related pain (2016) (0)
- Twenty-Four-Hour Symptom Control in Parkinson’s Disease, with Emphasis on Management of Nocturnal Disabilities (2001) (0)
- An international multicentre study validating the first screening questionnaire (NMS-quest) for comprehensive assessment of non motor symptoms of Parkinson's disease (2005) (0)
- Clinical Feasibility of Speech Phenotyping for Remote Assessment of Neurodegenerative and Psychiatric Disorders (RHAPSODY): a study protocol (2022) (0)
- Grey matter volume loss in Parkinson’s disease psychosis and its relationship with serotonergic gene expression: A meta-analysis (2023) (0)
- DaT-uptake z-scores for Caudate and Striatum Predict Levodopa Requirement in Early Parkinson’s Disease (S37.009) (2023) (0)
- Comprar Movement Disorders in Clinical Practice | Chaudhuri, K. Ray | 9781849960649 | Springer (2010) (0)
- Real‐life benefits of intrajejunal levodopa infusion therapy in four patients with the parkinsonian variant of progressive supranuclear palsy: A 1‐year follow‐up data report (2022) (0)
- Global Severity Assessments (2014) (0)
- 2.248 Improvement of nocturnal symptoms in patients with idiopathic Parkinson's disease using rotigotine transdermal (2007) (0)
- Pregnancy and movement disorders (2012) (0)
- Characterizing a Parkinson’s Disease Population Inadequately Controlled by Oral Therapy: Baseline Characteristics of the Phase 3 Clinical Program for Foslevodopa/Foscarbidopa (P2-11.006) (2023) (0)
- Sleep disturbances and gastrointestinal dysfunction are associated with thalamic atrophy in Parkinson’s disease (2019) (0)
- Non declaration of non motor symptoms (NMS) of PD: An international study using the NMSQuest (2009) (0)
- Manual of Pharmacology (2006) (0)
- NMDA Receptor Antibodies and Neuropsychiatric Symptoms in Parkinson's Disease. (2023) (0)
- Development and pilot study of the first nonmotor symptom screening questionnaire and scale for Parkinson's disease using an international multidisciplinary approach. (2004) (0)
- Imaging and behavior in Parkinson’s disease: structural imaging (2013) (0)
- The growth of the concept of nations in India (2016) (0)
- 1.297 Rotigotine transdermal patch is effective in the treatment of idiopathic RLS: Results of a 6 month, multicenter, double blind, placebo controlled trial in Europe (2007) (0)
This paper list is powered by the following services:
Other Resources About Kallol Ray Chaudhuri
What Schools Are Affiliated With Kallol Ray Chaudhuri?
Kallol Ray Chaudhuri is affiliated with the following schools:
